Prurigo Nodularis Clinical Trials

A listing of Prurigo Nodularis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 6 clinical trials
Featured trial
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Ranging Study of the Efficacy and Safety of INCB054707 in Participants With Prurigo Nodularis

The purpose of this study is to evaluate the efficacy and safety of INCB054707 in participants with prurigo nodularis over a 16-week double-blind placebo-controlled treatment period, followed by

  • 16 views
  • 28 Oct, 2022
  • 32 locations
Featured trial
Prurigo Nodularis

Prurigo nodularis (PN) is a condition that causes hard, itchy lumps (nodules) to form on the skin. Living with PN can be a challenge, as these lumps, or nodules, can be extremely itchy and

  • 0 views
  • 23 Sep, 2021
  • 1 location
Featured trial
A Phase 2b/3, Randomized, Double-Blind, Placebo-Controlled, 2-Arm, Efficacy, and Safety Study in Prurigo Nodularis with Nalbuphine ER Tablets for Pruritus Relief Through Itch Scratch Modulation (PRISM Study)

This study is testing the efficacy and safety of an oral medication in patients with Prurigo Nodularis for pruritis (severe itch) relief.  

  • 140 views
  • 23 Nov, 2020
  • 1 location
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Ranging Study of the Efficacy and Safety of INCB054707 in Participants With Prurigo Nodularis

The purpose of this study is to evaluate the efficacy and safety of INCB054707 in participants with prurigo nodularis over a 16-week double-blind placebo-controlled treatment period, followed by

  • 0 views
  • 28 Oct, 2022
  • 32 locations
A Double-Blind, Placebo-Controlled, Randomized Study to Assess the Durability of Effect and Safety of Nemolizumab for 24 Weeks in Subjects With Prurigo Nodularis

The primary objective of this study is to assess the long-term durability of response over a 24-week period following withdrawal of nemolizumab in participants with prurigo nodularis (PN) who

  • 0 views
  • 27 Oct, 2022
  • 5 locations
China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project (CORNERSTONE)

In order to further improve the diagnosis and treatment level of type 2 inflammatory skin diseases, the National Clinical Center for Skin and Immune Diseases established a standardized diagnosis and treatment center for type 2 inflammatory skin diseases to systematically and effectively understand the current treatment status of patients with …

  • 0 views
  • 25 Apr, 2022
  • 1 location